Respironics buys SpectRx infant jaundice monitor
This article was originally published in Clinica
Executive Summary
Respironics has acquired SpectRx's BiliChek biophotonic infant jaundice monitor for $4m, with an additional $7.25m payable over five years dependent on product development and sales.